Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).
Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).
Recruiting · NCT06623409 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of V540B in Healthy Adults (V540B-002). | Healthy | Recruiting | Phase 1 | 2026-10-08 | NCT06623409 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anaheim Clinical Trials ( Site 0002) | Anaheim | United States | 1 |
| Research Centers of America ( Hollywood ) ( Site 0001) | Hollywood | United States | 2 |
| Velocity Clinical Research, Hallandale Beach ( Site 0003) | Hallandale | United States | 3 |
| Velocity Clinical Research, Omaha ( Site 0005) | Omaha | United States | 2 |